(16 days)
No
The summary describes standard physiological monitoring and arrhythmia detection based on processing physiological data, without mentioning AI or ML. The performance studies focus on compliance with voluntary standards and comparison to predicate devices, not on AI/ML model performance metrics.
No.
The device is intended for monitoring physiological data and detecting events, not for treating or curing a condition.
Yes
The system is designed to acquire and monitor physiological data, process it to detect ECG arrhythmia events and physiological parameter limit violations, and display this data to clinicians for diagnostic purposes.
No
The device description explicitly lists multiple hardware components, including patient-worn transceivers, access points with antennas, and network infrastructure, in addition to the software applications running on computer platforms.
Based on the provided text, the ApexPro FH Telemetry System is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- ApexPro FH function: The ApexPro FH Telemetry System acquires and monitors physiological data directly from the patient (ECG, blood pressure, temperature, SpO2) using patient-worn devices. This is in vivo monitoring, not in vitro testing of samples.
- Intended Use: The intended use clearly states monitoring physiological data for ambulating patients and detecting events based on this data. It does not mention analyzing biological samples.
Therefore, the ApexPro FH Telemetry System falls under the category of patient monitoring devices, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The ApexPro FH Telemetry System is intended for use under the direct supervision of a licensed healthcare practitioner. The system is designed to acquire and monitor physiological data for ambulating patients within a defined coverage area. The system processes this physiological data to detect various ECG arrhythmia events and select physiological parameter limit violations.
The ApexPro FH Telemetry System is intended to be installed in the hospital or clinical environment in order to provide clinicians with patient physiological data, while allowing for patient mobility. These systems are typically deployed in sub acute care areas in hospitals or clinical sites where patient mobility can enhance the effectiveness of the medical procedures administered.
The physiological parameters monitored include ECG, non-invasive blood pressure, non-invasive temperature and SpO2. The ApexPro FH Telemetry System is intended to provide ECG data via Ethernet to the computer platform for processing. The ApexPro FH is also intended to provide physiologic data over the Unity network to clinical information systems for display.
Product codes
MHX
Device Description
The ApexPro FH Telemetry System is composed of six major components:
Accessories to the patient worn acquisition transceivers
The patient worn data acquisition transceivers
The transceiver access points with antenna
The network infrastructure
A computer platform running the ApexPro Telemetry Application
A computer platform running a central station application (which may be the same computer platform running the ApexPro Telemetry Application)
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
licensed healthcare practitioner.
hospital or clinical environment
sub acute care areas in hospitals or clinical sites
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Test Summary: The ApexPro FH complies with the voluntary standards as detailed in Section 9 of this submission. The following quality assurance measures were applied to the development of the system:
Requirements specification review.
Code inspections.
Software and hardware testing.
Safety testing.
Environmental testing.
. Final validation
The results of these measurements demonstrated that the ApexPro FH Conclusion: System is as safe, as effective, and performs as well as the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K032369 ApexPro Telemetry System
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
| Section 2 Summary | |
|---|---|
| 510(k) Summary of Safety and Effectiveness | |
| Date: | October 20, 2003 |
| Submitter: | GE Medical Systems Information Technologies |
| 8200 West Tower Avenue | |
| Milwaukee, WI 53223 USA | |
| Contact Person: | Diana M. Thorson |
| Regulatory Affairs Specialist | |
| GE Medical Systems Information Technologies | |
| Phone: 714-247-4135 | |
| Fax: 714-247-4155 | |
| Device: | |
| Trade Name: | ApexPro FH Telemetry System |
| Common/Usual Name: | Telemetry Monitoring System |
| Classification Names: | 21 CFR 870.1025 Detector and Alarm, Arrhythmia |
| 21 CFR 870.2910 Transmitters & Receivers, Physiological Signal, Radio Frequency | |
| Predicate Device: | K032369 ApexPro Telemetry System |
| Device Description: | The ApexPro FH Telemetry System is composed of six major |
| components: | |
| Accessories to the patient worn acquisition transceivers The patient worn data acquisition transceivers The transceiver access points with antenna The network infrastructure A computer platform running the ApexPro Telemetry Application A computer platform running a central station application (which may be the same computer platform running the ApexPro Telemetry Application) | |
| Intended Use: | The ApexPro FH Telemetry System is intended for use under the direct |
| supervision of a licensed healthcare practitioner. The system is | |
| designed to acquire and monitor physiological data for ambulating | |
| patients within a defined coverage area. The system processes this | |
| physiological data to detect various ECG arrhythmia events and select | |
| physiological parameter limit violations. | |
| The ApexPro FH Telemetry System is intended to be installed in the | |
| hospital or clinical environment in order to provide clinicians with patient | |
| physiological data, while allowing for patient mobility. These systems | |
| are typically deployed in sub acute care areas in hospitals or clinical | |
| sites where patient mobility can enhance the effectiveness of the | |
| medical procedures administered. | |
| The physiological parameters monitored include ECG, non-invasive | |
| blood pressure, non-invasive temperature and SpO2. The ApexPro FH | |
| Telemetry System is intended to provide ECG data via Ethernet to the | |
| computer platform for processing. The ApexPro FH is also intended to | |
| provide physiologic data over the Unity network to clinical information | |
| systems for display. |
1
- The ApexPro FH employs the same functional technology as the Technology: predicate devices. The system architecture has taken advantage of improvements in signal processing technology as well as advances in RF component technologies to improve performance and level of integration.
- Test Summary: The ApexPro FH complies with the voluntary standards as detailed in Section 9 of this submission. The following quality assurance measures were applied to the development of the system:
- Requirements specification review .
- Code inspections .
- Software and hardware testing .
- Safety testing .
- Environmental testing .
- . Final validation
- The results of these measurements demonstrated that the ApexPro FH Conclusion: System is as safe, as effective, and performs as well as the predicate devices.
2
Image /page/2/Picture/11 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of an eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV - 6 2003
GE Medical Systems Information Technologies c/o Ms. Diane M. Thorson Corporate Regulatory Affairs 8200 West Tower Avenue Milwaukee, WI 53223
Re: K033365
Trade Name: ApexPro FH Telemetry System Regulation Number: 21 CFR 870.1025 Regulation Name: Arrhythmia Detector and Alarm Regulatory Class: Class II (three) Product Code: MHX Dated: October 20, 2003 Received: October 21, 2003
Dear Ms. Thorson:
'We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Ms. Diane M. Thorson
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely vours.
Afgar May
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known):
510(k) filed on October 10, 2003
ApexPro FH Telemetry System Device Name:
Indications For Use:
The ApexPro FH Telemetry System is intended for use under the direct supervision of a licensed healthcare practitioner. The system is designed to acquire and monitor physiological data for ambulating patients within a defined coverage area. The system processes this physiological data to detect various ECG arrhythmia events and select physiological parameter limit violations.
The ApexPro FH Telemetry System is intended to be installed in the hospital or clinical environment in order to provide clinicians with patient physiological data, while allowing for patient mobility. These systems are typically deployed in sub acute care areas in hospitals or clinical sites where patient mobility can enhance the effectiveness of the medical procedures administered.
The physiological parameters monitored include ECG, non-invasive blood pressure, non-invasive temperature and SpO2. The ApexPro FH Telemetry System is intended to provide ECG data via Ethernet to the computer platform for processing. The ApexPro FH is also intended to provide physiologic data over the Unity network to clinical information systems for display.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) | ||
|---|---|---|
| (Division Sign-Off) | ||
| Division of Cardiovascular Devices | ||
| 510(k) Number | K033365 | |
Prescription Use_X (Per 21 CFR 801.109)
OR
Over-The-Counter Use
(Optional Format 1-2-96)